VFC
54
-7
SCHW
36
-6
SLB
39
-6
PH
56
-4
L
47
-7
AIV
58
-6
SNA
52
-6
HBAN
40
-11
MSFT
53
-11
UAL
63
-9
COP
36
-3
HRL
38
-4
AEP
39
-4
JNPR
56
-6
URI
33
-7
SPG
41
-12
YUM
36
-4
BK
58
-8
BWA
41
-5
MHK
18
-7
VFC
54
-7
SCHW
36
-6
SLB
39
-6
PH
56
-4
L
47
-7
AIV
58
-6
SNA
52
-6
HBAN
40
-11
MSFT
53
-11
UAL
63
-9
COP
36
-3
HRL
38
-4
AEP
39
-4
JNPR
56
-6
URI
33
-7
SPG
41
-12
YUM
36
-4
BK
58
-8
BWA
41
-5
MHK
18
-7
Financhill
Back

ProShares Ultra Dow30 Vs. Viking Therapeutics Industry Stock Comparison

Sell
50

DDM
ProShares Ultra Dow30

Last Price:
95.81
Seasonality Move:
-0.55%
Sell
28

VKTX
Viking Therapeutics

Last Price:
41.16
Seasonality Move:
40.87%
Sell
50
ProShares Ultra Dow30 (DDM) is a Sell

Is ProShares Ultra Dow30 a Buy, Sell or Hold?

  • The current ProShares Ultra Dow30 [DDM] share price is $94.74. The Score for DDM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • DDM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $38.28. The Score for VKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DDM Stock Price Chart

What is ProShares Ultra Dow30's stock price today?

  • The ProShares Ultra Dow30 share price today is $94.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DDM is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $38.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

DDM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 28.87 Sell
Chaikin Money Flow: -599474 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.96 - 106.12) Sell
Bollinger Bands (100): (88.84 - 101.74) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.91 Sell
Relative Strength Index (14 RSI): 23.24 Sell
Chaikin Money Flow: -10764092 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.91 - 53.55) Sell
Bollinger Bands (100): (52.21 - 67.17) Sell

DDM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.36 Sell
20-day SMA: 103.67 Sell
50-day SMA: 100.26 Sell
200-day SMA: 89.43 Buy
8-day EMA: 100.63 Sell
20-day EMA: 102.04 Sell
50-day EMA: 100.12 Sell
200-day EMA: 90.6 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.82 Sell
20-day SMA: 49.84 Sell
50-day SMA: 58.67 Sell
200-day SMA: 62.24 Sell
8-day EMA: 46.02 Sell
20-day EMA: 49.86 Sell
50-day EMA: 55.23 Sell
200-day EMA: 54.61 Sell

ProShares Ultra Dow30 Earnings Growth & DDM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.

ProShares Ultra Dow30 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):